MIT researchers have developed an ingestible sensor that can monitor vital signs, reports Rae Ellen Bichell for NPR. "Trauma patients are a really clear winner here, because we can do vital sign monitoring without touching the skin," says Albert Swiston of Lincoln Laboratory.
In an article for Stat, Andrew Joseph writes that the Commonwealth Foundation for Cancer Research is committing $20 million to the Bridge Project, which funds research at the Koch Institute and Dana-Farber. “We’re looking for the best people, regardless of where they are, to tackle these very important problems,” explains Tyler Jacks, director of the Koch Institute.
MIT researchers have developed a new method of delivering drugs to the gastrointestinal tract via ultrasound waves, reports Alexandra Ossola of Popular Science. The new drug-delivery method could prove effective in treating diseases like Crohn’s and ulcerative colitis.
Robert Preidt writes for U.S. News & World Report that MIT researchers have found that ultrasound waves can be used to deliver drugs to the digestive system. Preidt explains that the new approach, “might potentially benefit people with inflammatory bowel disease (IBD), such as Crohn's disease and ulcerative colitis.”
MIT researchers have developed an ultrasound device that can deliver medication to the digestive system, reports Leah Samuel for The Boston Globe. The researchers “found that using ultrasound enhanced absorption of the drugs they tested up to tenfold,” writes Samuel.
Lindsay Kalter reports for The Boston Herald that researchers from MIT, Philips, and Boston Medical Center are developing a non-invasive way to diagnose head injuries. Kalter explains that the study is part of a new collaboration between MIT and Philips and will “use data from an ultrasound machine taking measurements of blood pressure and flow.”
Researchers from MIT, Philips and Boston Medical Center are collaborating on new technology to diagnose brain injuries, reports Nidhi Subbaraman for BetaBoston. “The goal is to investigate whether ultrasound readers can help doctors assess the severity of a head injury,” Subbaraman writes.
In an article for The New York Times about the impact of patent laws on drug development, Austin Frakt highlights Prof. Benjamin Roin’s research that indicates pharmaceutical companies reject unpatentable drugs. To counter this problem, Frakt explains that Roin suggests “a period of market exclusivity…to any organization addressing an unmet medical need with a drug that isn’t patentable.”
The MIT Hacking Medicine group is collaborating with the Spaulding Rehabilitation Center to host the first-ever hackathon devoted to rehabilitation, reports Dana Guth for Boston Magazine. “A healthcare hackathon is an increasingly popular forum for students, medical professionals, and inventors to come together and solve major issues in the medical world,” writes Guth.
CNBC’s Robert Ferris reports that researchers at MIT and Boston Children’s Hospital have devised a new method to create 3-D heart models. The new technique allows doctors to 3-D print replicas of a patient’s heart within 24 hours, making it practical for hospital use, Ferris explains.
Researchers at MIT and Boston Children’s Hospital are developing a new technique to convert images from MRI scans into physical models of the human heart, writes Lindsay Kalter for The Boston Herald. “This can definitely impact clinical practice in terms of helping surgeons plan more efficiently,” explains graduate student Danielle Pace.
“Researchers from MIT and Boston Children’s Hospital say they’ve come up with a better, faster way to build heart models,” writes Barb Darrow for Fortune. The team has devised a method for 3-D printing model hearts from MRI scans that takes three to four hours compared to the 10 hours typically required using current methods.
An article in The Economist highlights how a number of researchers at MIT are developing new devices to regulate the delivery of drugs within the body. Prof Michael Cima is working on a drug-delivery technology that could be used to treat ovarian cancer.
Researchers at MIT and Harvard have developed a new device that can quickly detect Ebola, reports Robert Preidt for U.S. News & World Report. “The new paper-based test takes minutes and the device does not require electricity,” writes Preidt. “The test works in a similar manner to over-the-counter pregnancy tests.”
A team led by Prof. Michael Cima is developing an implantable sensor that can monitor a tumor’s response to cancer drugs, writes Eric Levenson for Boston.com. “The sensor would function like a long-term medical biopsy, giving doctors a continuous look at how a tumor is developing,” Levenson explains.